The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy
Golnaz Sadjadieh1*, MD; Thomas Engstrøm1, MD, DMSc; Steffen Helqvist1, MD, DMSc; Dan Eik Høfsten1, MD, PhD; Lars Køber1, MD, DMSc; Frants Pedersen1, MD, PhD; Peter Clemmensen2,3,4, MD, DMSc; Erik Jørgensen1, MD; Kari Saunamäki1, MD, DMSc; Hans-Henrik Tilsted5, MD; Henning Kelbæk6, MD, DMSc; Lene Holmvang1, MD, DMSc
1. Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark; 2. Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany; 3. Department of Medicine, Nykøbing F Hospital, Nykøbing F, Denmark; 4. Un
Aims: The aim of this study was to evaluate whether a staged in-hospital complete revascularisation strategy increases the risk of serious bleeding events in patients with ST-segment elev